TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ADCT

ADC Therapeutics SA

Healthcare · Biotechnology

1.10$ +1.0% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

ADC Therapeutics SA (ADCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 81 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ADCT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
1.8 1.1 2.3 0.0 34 210 70 71 81
86 118 108 142 1.4 3.3 2.5 5.9 7.7
-84 -117 2.3 -142 33 207 67 65 74
86 118 108 142 158 186 127 110 104
7.8 8.6 14 55 71 108 73 64 37
93 127 122 77 294 330 233 196 182
-92 -126 -119 -219 -262 -123 -166 -131 -108
2.7 3.3 0.2 4.9 18 37 46 50 52
-90 -123 -116 -246 -252 -157 -201 -158 -143
0.0 0.2 0.6 0.3 -21 0.2 39 0.2 -0.2
-90 -123 -116 -246 -230 -157 -240 -158 -143
-91 -122 -114 -218 -231 -108 -146 -103 -89

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?